Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Earnings Call Summary | LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD(LZAGY.US) Q1 2024 Earnings Conference
The following is a summary of the Lonza Group AG (LZAGY) Q1 2024 Earnings Call Transcript:Financial Performance:Lonza Group reported softer Q1 performance but expects alignment with the year's traject
Q1 2024 Qualitative Update: Performance In Line With Expectations for Full-Year 2024
Q1 2024 Qualitative Update: Performance In Line with Expectations for Full-Year 2024 Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s Softer performance in Q1 2024, normal
LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD To Go Ex-Dividend On May 15th, 2024 With 0.22085 USD Dividend Per Share And 0.22085 USD Special Dividend Per Share
May 14th - $LONZA GROUP AG UNSP ADR EACH REP 0.1 ORD(LZAGY.US)$ is trading ex-dividend on May 15th, 2024. Shareholders of record on May 16th, 2024 will receive 0.22085 USD dividend per share and 0
Lonza Prices EUR 1 Billion Straight Bond With a 3.875% Coupon
Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon Basel, Switzerland, 17 April 2024 – Lonza Finance International NV, a wholly owned company of Lonza Group Ltd, Basel ("Lonza"), announced
Lonza Group AG's (VTX:LONN) Largest Shareholders Are Individual Investors With 56% Ownership, Institutions Own 44%
Lonza Appoints New CEO
15 Biggest Swiss Companies
Swiss Healthcare Manufacturing Firm Lonza Bolsters Biologics Manufacturing Capacity With Roche's US Facility Acquisition For $1.2B
Wednesday, Roche Holding AG (OTC:RHHBY) entered into a definitive agreement with Lonza Group Ltd (OTC:LZAGF) (OTC:LZAGY).Under the agreement, Lonza will acquire the Genentech manufacturing facility in
UPDATE 1-Luxury Stocks Drag European Equities Lower Ahead of Fed Meeting
UPDATE 1-Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Bln
Lonza to Buy Biologics Site From Roche in U.S. for $1.2 Billion
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) From Roche
Lonza Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from RocheLonza has signed an agreement to acquire the Genentech manufacturing facility in Vacaville (US) from Roche for U
Lonza Group's (VTX:LONN) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Booming Weight-loss Drug Market to Lift "pick-and-shovel" Plays: Jefferies
30 Most Valuable Drug Companies in 2024
Lonza Group Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Lonza Group (VTX:LONN) Full Year 2023 Results
Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript Summary
The following is a summary of the Lonza Group AG (LZAGY) Q4 2023 Earnings Call Transcript:Financial Performance:Lonza reported group sales of CHF 6.7 billion in 2023, showing a growth of 10.9%.Profits
Lonza Group AG Non-GAAP EPS of CHF12.39, Revenue of CHF6.72B
Lonza Names Heineken's Jean-Marc Huet as Next Chairman
Lonza Group has proposed Jean-Marc Huet, currently chairman of Dutch brewer Heineken, as its next chair to replace Albert Baehny.
No Data